The role of procalcitonin in a decision tree for prediction of bloodstream infection in febrile patients  R.P.H. Peters, J.W.R. Twisk, M.A. van Agtmael,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P.-Y. Lévy  Clinical Microbiology and Infection 
Procalcitonin to guide taking blood cultures in the intensive care unit; a cluster- randomized controlled trial  P.J. van der Geest, M. Mohseni, D. Nieboer,
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.
Herpes zoster in non-hospitalized children
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.
Migrant health—a cause for concern?
A.G. Koek, S.M. Bruisten, M. Dierdorp, A.P. van Dam, K. Templeton 
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
A.K. Reddy, P. Garg, I. Kaur  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
A guide to interpreting economic studies in infectious diseases
B. Beović, S. Kreft, J. Osredkar, D. Keše, B. Bonač-Tuma 
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
E. Braun, K. Hussein, Y. Geffen, G. Rabino, Y. Bar-Lavie, M. Paul 
Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland  E. Sarvikivi, O. Lyytikäinen, M. Vaara, H.
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
S. Richard, P. Seng, P. Parola, D. Raoult, B. Davoust, P. Brouqui 
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
P. Seng, J.M. Rolain, D. Raoult, P. Brouqui 
Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever?  S. Edouard, A. Michel-Lepage, D. Raoult 
Laboratory diagnosis and biosafety issues of biological warfare agents
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
S.H. Hoeboer, P.J. van der Geest, D. Nieboer, A.B.J. Groeneveld 
Laboratory diagnosis of Clostridium difficile disease
Whole genome-based phylogenetic analysis of Rickettsiae
The practice of travel medicine in Europe
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Current experience in treating invasive zygomycosis with posaconazole
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Clinical infection services—the Leiden experience
Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Leishmaniasis in immunosuppressed individuals
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre  R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli 
Abstracts Clinical Microbiology and Infection
Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers 
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

The role of procalcitonin in a decision tree for prediction of bloodstream infection in febrile patients  R.P.H. Peters, J.W.R. Twisk, M.A. van Agtmael, A.B.J. Groeneveld  Clinical Microbiology and Infection  Volume 12, Issue 12, Pages 1207-1213 (December 2006) DOI: 10.1111/j.1469-0691.2006.01556.x Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Decision tree analysis with peak procalcitonin (PCT) as the principal discriminator for prediction of bloodstream infection (BSI) in patients with fever (n = 262). (a) Branch of the decision tree in cases where peak PCT was ≥2.45 ng/mL. (b) Branch with peak PCT levels that are lower than the cut-off value. Endpoint boxes include outcome (BSI or No BSI), probability (Pr) of outcome, and number (n) of cases included in the node during analysis. ASAT, aspartate aminotransferase; RR, respiratory rate. Clinical Microbiology and Infection 2006 12, 1207-1213DOI: (10.1111/j.1469-0691.2006.01556.x) Copyright © 2006 European Society of Clinical Infectious Diseases Terms and Conditions